Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Membrane Protein Structure Visualized Using Emerging X-Ray Technology despite Existing Damage

By LabMedica International staff writers
Posted on 23 Jan 2011
Australian researchers have found a way to measure the structure of membrane proteins in spite of being damaged when using X-ray free-electron lasers (XFELs), a discovery that will help fast track the development of targeted drugs using new XFELs technology. More...


Approximately 70% of drugs on the market today depend on the activity of membrane proteins, which are complex molecules that form the membranes of the cells in our body. A major problem for the design of new pharmaceuticals, often known as the "membrane protein problem,” is that they do not form the crystals needed to enable further investigation of the structure to design better drugs.

A large international effort is being undertaken to determine the structures of membrane proteins using XFELs--large facilities that create such a bright beam of X-rays it is possible to see the X-ray light bouncing off a single molecule without forming a crystal.

Prof. Keith Nugent, and ARC Federation fellow and director of the Australian Research Council Center of Excellence for Coherent X-ray Science (CXS) at the University of Melbourne (Australia) reported that a key problem was that the light from an XFEL was so bright a molecule would start to disintegrate in less than one thousandth of a millionth of a millionth of a second.

In an article published online December 19, 2010, in the journal Nature Physics, Prof. Nugent and Associate Prof. Harry Quiney from the ARC Center of Excellence for Coherent X-ray Science (CXS) have developed a method by which the damage from the XFEL pulse may be included in the data analysis. Associate Prof. Quiney, also from the School of Physics at the University of Melbourne, reported that the study's findings revealed that high-resolution molecular structures may be obtained from X-ray scattering data using a few-femtosecond pulse from an XFEL, even if the interaction resulted in significant electronic damage to the target. "This result has far-reaching implications for the future development of structural biology, because it removes a significant obstacle to the practical realization of the molecular microscope using XFEL sources,” he said.

The technology also provides significant clues into the complex, raging, and little-understood interactions that are driven by the interaction of an XFEL pulse with an atom, molecule, or solid. The scientists' approach uses advanced molecular physics and precise data analysis to determine a new approach to measuring molecular structure. Although still at the theoretic and computation level when put into practice, this finding should remove a major hurdle in the path to solving the membrane protein problem.

In 2010, CXS signed an agreement with Japanese colleagues and will host the 4th Asia-Oceania Workshop on Science with X-ray Free Electron Lasers in 2011.

Prof. Nugent noted that this was an extremely exciting time for X-ray science. "My colleagues and I are convinced that our recent work is a critically important step forward,” he said. "We are very much looking forward to working with our Japanese colleagues in the coming years.”

The first XFEL began operating at Stanford University in Palo Alto, CA, USA, in 2009 and the second, the SPring8 facility in Harima Science Park City, Hyogo Prefecture, Japan, will start in 2011. A third is under construction in Europe to commence in 2014.

Related Links:
University of Melbourne



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Portable Electronic Pipette
Mini 96
New
Pipette
Accumax Smart Series
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.